BIO Bio-Rad Laboratories
$368.83 -2.89%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-2.89%
YTD
+24.40%
P/E
44.07
P/B
1.1
ROE
3.1%
Div yield
—
Beta
0.71
Market cap
$9.8B
RSI (14)
47
Next earnings
Oct 22, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$383.38
Close
$368.83
VWAP (n/a)
—
Day high
$390.00
Day low
$367.49
Volume
162K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Recombinant Proteins Manufacturing Services Market Report Released; 19.7% CAGR as revenue nearly triples from $5.2B to $15.3B by 2030; benchmark WuXi Biologics, GenScript, Bio-Rad, ACROBiosystems and Syngene amid tariff disruption
Yahoo Finance · Oct 1
Why Bio Rad Laboratories (BIO) Is Back In The Spotlight
Yahoo Finance · Oct 1
Bio-Rad Laboratories Bets on Digital PCR, Margins and Smarter M&A Growth
Yahoo Finance · Sep 26
Cell Isolation/Cell Separation Market Forecasts Growth from $6.97B (2026) to $13.51B by 2032, Profiling Thermo Fisher, Bio-Rad, Beckman Coulter & Sartorius
Yahoo Finance · Sep 24
Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher
Yahoo Finance · Sep 24
Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum
Yahoo Finance · Sep 16
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 4, 2026 View → 8-K Aug 4, 2026 View → 10-Q Apr 30, 2026 View → 8-K Apr 30, 2026 View → 8-K Apr 24, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell BIO. Try it in the Lab to size a position and see the risk.